A HOLLANDER
Overview
Explore the profile of A HOLLANDER including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
FRIEDMANN U, HOLLANDER A, TRAUB F
Fed Proc
. 2010 Nov;
5(1 Pt 2):247.
PMID: 21064594
No abstract available.
2.
FRIEDEMANN U, HOLLANDER A, TRAUB F
J Immunol
. 2010 Oct;
52:247-57.
PMID: 21018827
No abstract available.
3.
4.
TRAUB F, HOLLANDER A, FRIEDEMANN U
J Bacteriol
. 2010 Oct;
52:169-77.
PMID: 20995930
No abstract available.
5.
HOLLANDER A, Scheringer M, Shatalov V, Mantseva E, Sweetman A, Roemer M, et al.
J Environ Monit
. 2008 Oct;
10(10):1139-47.
PMID: 18843390
Two different approaches to modeling the environmental fate of organic chemicals have been developed in recent years. The first approach is applied in multimedia box models, calculating average concentrations in...
6.
Weiland O, HOLLANDER A, Mattsson L, Glaumann H, Lindahl K, Schvarcz R, et al.
J Viral Hepat
. 2008 May;
15(9):641-5.
PMID: 18507753
Mono-therapy with pegylated interferon (peg-IFN) has shown that a lower-than-standard dose yields the same sustained viral response (SVR) rates as standard doses for chronic hepatitis C virus (HCV) infection caused...
7.
Candrian C, Vonwil D, Barbero A, Bonacina E, Miot S, Farhadi J, et al.
Arthritis Rheum
. 2008 Jan;
58(1):197-208.
PMID: 18163475
Objective: To determine whether engineered cartilage generated by nasal chondrocytes (ECN) is responsive to different regimens of loading associated with joint kinematics and previously shown to be stimulatory of engineered...
8.
Sharma A, HOLLANDER A, Koster J
Clin Nephrol
. 2005 Apr;
63(4):250-7.
PMID: 15847251
Aims: This study assessed the clinical efficacy and safety of telmisartan, an angiotensin II receptor blocker with a long terminal elimination half-life and almost exclusively excreted in bile, in patients...
9.
HOLLANDER A, Hessels L, de Voogt P, van de Meent D
SAR QSAR Environ Res
. 2005 Jan;
15(5-6):457-68.
PMID: 15669702
In standard multimedia mass balance models, the soil compartment is modeled as a box with uniform concentrations, which often does not correspond with actual field situations. Therefore, the theoretically expected...
10.
HOLLANDER A, Glaumann H, Weiland O
Scand J Gastroenterol
. 2004 Mar;
39(2):164-7.
PMID: 15000279
Background: Genotype distribution of chronic hepatitis C in Sweden has shown a predominance of genotype non-1. With recent improvements in therapy, genotypes 2 and 3 infections can, according to consensus,...